Activated Partial Thromboplastin Time and Mortality in Coronary Artery Bypass Grafting Patients

Table 3

Outcome of the study patients before and after PSM.

Outcomes	Total			value
Before PSM
Number				value
ICU LOS (days)	2.5 (1.4-4.3)	2.2 (1.3-3.9)	3.4 (2.1-6.7)	<0.001
Mortality, (%)
In-hospital mortality	48 (1.8)	15 (0.7)	33 (4.7)	<0.001
30-day mortality	59 (2.2)	22 (1.1)	37 (5.3)	<0.001
90-day mortality	103 (3.8)	42 (2.1)	61 (8.7)	<0.001
1-year mortality	188 (6.9)	89 (4.4)	99 (14.2)	<0.001
4-year mortality	431 (15.9)	251 (12.5)	180 (25.8)	<0.001
After PSM
Number				value
ICU LOS (days)	3.0 (1.9-5.2)	2.3 (1.4-4.2)	3.3 (2.1-6.2)	<0.001
Mortality, (%)
In-hospital mortality	32 (2.5)	10 (1.6)	22 (3.4)	0.049
30-day mortality	37 (2.9)	11 (1.7)	26 (4.1)	0.020
90-day mortality	70 (5.5)	23 (3.6)	47 (7.3)	0.005
1-year mortality	131 (10.2)	53 (8.3)	78 (12.2)	0.027
4-year mortality	259 (20.2)	107 (16.7)	152 (23.8)	0.002

ICU LOS: length of ICU stays.